If things turn out OK with the phase 3 trofinetide trial, then NEU can go all the way with 2591 on their own - huge considering their expectations for the second arrow in their quiver.
- Forums
- ASX - By Stock
- NEU
- Ann: Update on development plan for NNZ-2591
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.32%
!
$12.50

Ann: Update on development plan for NNZ-2591, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.50 |
Change
-0.040(0.32%) |
Mkt cap ! $1.563B |
Open | High | Low | Value | Volume |
$12.61 | $12.68 | $12.34 | $1.957M | 156.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 181 | $12.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.51 | 364 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 19 | 12.530 |
11 | 374 | 12.520 |
4 | 443 | 12.510 |
5 | 1043 | 12.500 |
4 | 1229 | 12.490 |
Price($) | Vol. | No. |
---|---|---|
12.540 | 399 | 6 |
12.550 | 560 | 4 |
12.560 | 1475 | 5 |
12.570 | 1320 | 4 |
12.580 | 1406 | 6 |
Last trade - 11.13am 25/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |